| ion transmembrane transport | GO:0034220 | 361 | 0.319 | |
| kidney development | GO:0001822 | 213 | 0.311 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.265 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.265 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.224 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.224 | |
| urogenital system development | GO:0001655 | 261 | 0.206 | |
| spemann organizer formation | GO:0060061 | 2 | 0.190 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.177 | |
| oviduct development | GO:0060066 | 3 | 0.174 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.169 | |
| male gamete generation | GO:0048232 | 285 | 0.167 | |
| forebrain development | GO:0030900 | 302 | 0.159 | |
| renal outer medulla development | GO:0072054 | 2 | 0.156 | |
| renal system development | GO:0072001 | 225 | 0.155 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.139 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.138 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.131 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.129 | |
| gland development | GO:0048732 | 330 | 0.128 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.127 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.124 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.124 | |
| sodium ion transport | GO:0006814 | 73 | 0.121 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.120 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.117 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.116 | |
| regulation of anagen | GO:0051884 | 1 | 0.114 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.112 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.112 | |
| hormone metabolic process | GO:0042445 | 86 | 0.110 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.106 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.105 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.104 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.104 | |
| metanephros development | GO:0001656 | 79 | 0.103 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.102 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.101 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.101 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.100 | |
| transmembrane transport | GO:0055085 | 412 | 0.098 | |
| epithelial cell development | GO:0002064 | 159 | 0.098 | |
| cation transport | GO:0006812 | 399 | 0.097 | |
| stem cell differentiation | GO:0048863 | 268 | 0.095 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.093 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.090 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.090 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.088 | |
| mapk cascade | GO:0000165 | 281 | 0.086 | |
| menarche | GO:0042696 | 1 | 0.085 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.084 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.082 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.082 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.081 | |
| cerebral cortex neuron differentiation | GO:0021895 | 19 | 0.080 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.078 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.078 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.077 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.075 | |
| spermatogenesis | GO:0007283 | 284 | 0.073 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.071 | |
| regulation of cell migration | GO:0030334 | 219 | 0.070 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.068 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.067 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.064 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.064 | |
| synapse organization | GO:0050808 | 125 | 0.064 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.064 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.063 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.063 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.062 | |
| globus pallidus development | GO:0021759 | 2 | 0.062 | |
| digestive tract development | GO:0048565 | 190 | 0.062 | |
| leukocyte migration | GO:0050900 | 124 | 0.060 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.060 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.060 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.060 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.059 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.059 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.059 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.058 | |
| rhythmic process | GO:0048511 | 174 | 0.058 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.057 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.057 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.057 | |
| cerebellum formation | GO:0021588 | 1 | 0.057 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.056 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.056 | |
| pallium development | GO:0021543 | 120 | 0.055 | |
| hindbrain formation | GO:0021576 | 1 | 0.055 | |
| spermatid development | GO:0007286 | 108 | 0.054 | |
| developmental maturation | GO:0021700 | 193 | 0.054 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.054 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.053 | |
| ureteric bud development | GO:0001657 | 94 | 0.053 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.052 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.052 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.052 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.051 | |
| skin development | GO:0043588 | 220 | 0.051 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.051 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.051 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.050 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.050 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.050 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.050 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.050 | |
| spermatid differentiation | GO:0048515 | 115 | 0.050 | |
| dna metabolic process | GO:0006259 | 303 | 0.050 | |
| ventral spinal cord interneuron fate determination | GO:0060580 | 1 | 0.049 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.049 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.049 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.048 | |
| protein catabolic process | GO:0030163 | 221 | 0.048 | |
| olfactory bulb development | GO:0021772 | 30 | 0.047 | |
| cervix development | GO:0060067 | 2 | 0.047 | |
| germ cell development | GO:0007281 | 185 | 0.047 | |
| amine metabolic process | GO:0009308 | 45 | 0.047 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.046 | |
| sensory perception | GO:0007600 | 245 | 0.046 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.046 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.046 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.046 | |
| adult behavior | GO:0030534 | 135 | 0.045 | |
| organ growth | GO:0035265 | 117 | 0.045 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.045 | |
| ear development | GO:0043583 | 200 | 0.045 | |
| endocrine system development | GO:0035270 | 98 | 0.045 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.045 | |
| muscle system process | GO:0003012 | 141 | 0.045 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.045 | |
| regulation of secretion | GO:0051046 | 274 | 0.045 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.045 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.045 | |
| organic acid transport | GO:0015849 | 101 | 0.045 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.045 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.044 | |
| intracellular protein transport | GO:0006886 | 204 | 0.044 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.044 | |
| renal vesicle induction | GO:0072034 | 3 | 0.044 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.043 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.043 | |
| clara cell differentiation | GO:0060486 | 4 | 0.042 | |
| cell maturation | GO:0048469 | 127 | 0.042 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.042 | |
| stem cell development | GO:0048864 | 219 | 0.042 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.041 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.041 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.041 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.041 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.041 | |
| calcium ion transport | GO:0006816 | 159 | 0.041 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.041 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.041 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.041 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.041 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.041 | |
| renal inner medulla development | GO:0072053 | 3 | 0.040 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.040 | |
| ectoderm formation | GO:0001705 | 3 | 0.040 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.039 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.039 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.039 | |
| t cell activation | GO:0042110 | 289 | 0.038 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.038 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.038 | |
| skeletal system development | GO:0001501 | 356 | 0.038 | |
| germ line stem cell division | GO:0042078 | 2 | 0.038 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.038 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.038 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.038 | |
| lung induction | GO:0060492 | 3 | 0.037 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.037 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.037 | |
| regulation of cell motility | GO:2000145 | 236 | 0.037 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.036 | |
| protein ubiquitination | GO:0016567 | 171 | 0.035 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.035 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.035 | |
| nephron development | GO:0072006 | 109 | 0.035 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.035 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.034 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.034 | |
| atrioventricular node cell development | GO:0060928 | 2 | 0.034 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.034 | |
| forebrain neuron development | GO:0021884 | 30 | 0.034 | |
| macromolecule methylation | GO:0043414 | 120 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.034 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.034 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.033 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.033 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.033 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.033 | |
| cerebral cortex development | GO:0021987 | 86 | 0.033 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.033 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.033 | |
| nephric duct formation | GO:0072179 | 4 | 0.033 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.032 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.032 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.032 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.032 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.032 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.032 | |
| methylation | GO:0032259 | 134 | 0.032 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.032 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.032 | |
| organelle fission | GO:0048285 | 170 | 0.032 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.032 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.031 | |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.031 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.031 | |
| neurohypophysis development | GO:0021985 | 2 | 0.031 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.031 | |
| mesenchyme development | GO:0060485 | 152 | 0.031 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.031 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.031 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.030 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.030 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.030 | |
| paraxial mesoderm development | GO:0048339 | 18 | 0.030 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.030 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.029 | |
| mesonephros development | GO:0001823 | 97 | 0.029 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.029 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.029 | |
| sperm motility | GO:0030317 | 47 | 0.029 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.029 | |
| metanephric nephron development | GO:0072210 | 34 | 0.029 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.029 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.029 | |
| regulation of kidney development | GO:0090183 | 40 | 0.029 | |
| tissue homeostasis | GO:0001894 | 115 | 0.029 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.029 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.028 | |
| neuron migration | GO:0001764 | 122 | 0.028 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.028 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.028 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.028 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.028 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.028 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.028 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.028 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.028 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.028 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.028 | |
| neuron death | GO:0070997 | 154 | 0.028 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.028 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.028 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.028 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.028 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.028 | |
| developmental induction | GO:0031128 | 34 | 0.027 | |
| nephron epithelium development | GO:0072009 | 92 | 0.027 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.027 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.027 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.027 | |
| limb morphogenesis | GO:0035108 | 149 | 0.027 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.027 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.027 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.027 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.027 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.027 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.026 | |
| response to pain | GO:0048265 | 26 | 0.026 | |
| chemotaxis | GO:0006935 | 247 | 0.026 | |
| mesoderm development | GO:0007498 | 100 | 0.026 | |
| circulatory system process | GO:0003013 | 197 | 0.026 | |
| type b pancreatic cell fate commitment | GO:0003327 | 1 | 0.026 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.026 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.026 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.026 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.026 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.025 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.025 | |
| protein targeting | GO:0006605 | 143 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.025 | |
| cellular homeostasis | GO:0019725 | 240 | 0.025 | |
| regulation of protein transport | GO:0051223 | 163 | 0.025 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.025 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.025 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.025 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.025 | |
| regulation of ion transport | GO:0043269 | 215 | 0.025 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.025 | |
| locomotory behavior | GO:0007626 | 195 | 0.025 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.024 | |
| t cell differentiation | GO:0030217 | 174 | 0.024 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.024 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.024 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.024 | |
| muscle contraction | GO:0006936 | 101 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.024 | |
| heart morphogenesis | GO:0003007 | 178 | 0.024 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.024 | |
| lateral inhibition | GO:0046331 | 1 | 0.024 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.024 | |
| pulmonary myocardium development | GO:0003350 | 3 | 0.024 | |
| limb development | GO:0060173 | 166 | 0.024 | |
| pole plasm assembly | GO:0007315 | 2 | 0.024 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.024 | |
| negative regulation of growth | GO:0045926 | 99 | 0.024 | |
| peripheral nervous system neuron axonogenesis | GO:0048936 | 3 | 0.024 | |
| cerebral cortex gabaergic interneuron differentiation | GO:0021892 | 9 | 0.024 | |
| telencephalon development | GO:0021537 | 186 | 0.024 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.023 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.023 | |
| positive regulation of synapse assembly | GO:0051965 | 18 | 0.023 | |
| platelet activation | GO:0030168 | 40 | 0.023 | |
| nuclear transport | GO:0051169 | 139 | 0.023 | |
| epidermis development | GO:0008544 | 187 | 0.023 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.023 | |
| glycosylation | GO:0070085 | 62 | 0.023 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.023 | |
| cell adhesion | GO:0007155 | 329 | 0.023 | |
| gtp catabolic process | GO:0006184 | 143 | 0.023 | |
| gas homeostasis | GO:0033483 | 3 | 0.023 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.022 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.022 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.022 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.022 | |
| camera type eye development | GO:0043010 | 266 | 0.022 | |
| germline stem cell asymmetric division | GO:0098728 | 2 | 0.022 | |
| regulation of defense response | GO:0031347 | 233 | 0.022 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.022 | |
| synaptic transmission | GO:0007268 | 329 | 0.022 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.022 | |
| septum transversum development | GO:0003343 | 2 | 0.022 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.022 | |
| dephosphorylation | GO:0016311 | 129 | 0.022 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.022 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.022 | |
| connective tissue development | GO:0061448 | 179 | 0.021 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.021 | |
| regulation of cell activation | GO:0050865 | 289 | 0.021 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.021 | |
| foregut regionalization | GO:0060423 | 3 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.021 | |
| rna interference | GO:0016246 | 2 | 0.021 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.021 | |
| regulation of axon diameter | GO:0031133 | 6 | 0.021 | |
| hormone secretion | GO:0046879 | 128 | 0.021 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.021 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.021 | |
| mesoderm formation | GO:0001707 | 62 | 0.021 | |
| metanephric nephron tubule development | GO:0072234 | 16 | 0.021 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.021 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.021 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.021 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.021 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.021 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.021 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.021 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.020 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.020 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.020 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.020 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.020 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.020 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.020 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.020 | |
| positive regulation of dna templated transcription initiation | GO:2000144 | 5 | 0.020 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.020 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.020 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.020 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.020 | |
| acid secretion | GO:0046717 | 33 | 0.020 | |
| hair cycle | GO:0042633 | 90 | 0.020 | |
| natural killer cell chemotaxis | GO:0035747 | 1 | 0.020 | |
| excretion | GO:0007588 | 22 | 0.020 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.020 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.020 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.020 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.019 | |
| chromatin organization | GO:0006325 | 206 | 0.019 | |
| kidney epithelium development | GO:0072073 | 121 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| lung field specification | GO:0060424 | 3 | 0.019 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.019 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.019 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.019 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.019 | |
| cell fate commitment | GO:0045165 | 210 | 0.019 | |
| nephric duct elongation | GO:0035849 | 1 | 0.019 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.019 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.019 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.019 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.019 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.019 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.019 | |
| proepicardium development | GO:0003342 | 2 | 0.019 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.019 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.018 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.018 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.018 | |
| regulation of neuron death | GO:1901214 | 134 | 0.018 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.018 | |
| trabecula formation | GO:0060343 | 24 | 0.018 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.018 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.018 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.018 | |
| positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0072108 | 3 | 0.018 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.018 | |
| middle ear morphogenesis | GO:0042474 | 23 | 0.018 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.018 | |
| positive regulation of growth | GO:0045927 | 104 | 0.018 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.018 | |
| cation homeostasis | GO:0055080 | 212 | 0.018 | |
| cartilage development | GO:0051216 | 140 | 0.018 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.018 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.018 | |
| regulation of protein localization | GO:0032880 | 231 | 0.018 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.018 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 2 | 0.018 | |
| protein localization to organelle | GO:0033365 | 185 | 0.018 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.017 | |
| positive regulation of meiosis i | GO:0060903 | 5 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| metanephric nephron morphogenesis | GO:0072273 | 19 | 0.017 | |
| endocytosis | GO:0006897 | 168 | 0.017 | |
| regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003339 | 5 | 0.017 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.017 | |
| neuronal action potential | GO:0019228 | 54 | 0.017 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.017 | |
| cerebral cortex radially oriented cell migration | GO:0021799 | 31 | 0.017 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.017 | |
| cellularization | GO:0007349 | 1 | 0.017 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.017 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.017 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.017 | |
| limbic system development | GO:0021761 | 72 | 0.017 | |
| lipid modification | GO:0030258 | 65 | 0.017 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.017 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.017 | |
| nephron tubule development | GO:0072080 | 84 | 0.017 | |
| hydrogen transport | GO:0006818 | 35 | 0.017 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.016 | |
| male meiosis | GO:0007140 | 37 | 0.016 | |
| proton transport | GO:0015992 | 35 | 0.016 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.016 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.016 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.016 | |
| pituitary gland development | GO:0021983 | 38 | 0.016 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.016 | |
| neuromuscular process | GO:0050905 | 99 | 0.016 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.016 | |
| positive regulation of granulocyte macrophage colony stimulating factor production | GO:0032725 | 3 | 0.016 | |
| defense response to other organism | GO:0098542 | 197 | 0.016 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.016 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.016 | |
| regulation of system process | GO:0044057 | 200 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| epithelial tube formation | GO:0072175 | 130 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.016 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.016 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.016 | |
| forebrain cell migration | GO:0021885 | 58 | 0.016 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.016 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.016 | |
| organelle assembly | GO:0070925 | 177 | 0.016 | |
| renal system process | GO:0003014 | 48 | 0.016 | |
| dna alkylation | GO:0006305 | 43 | 0.016 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.016 | |
| granulocyte macrophage colony stimulating factor production | GO:0032604 | 3 | 0.016 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.016 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.015 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.015 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.015 | |
| neural tube development | GO:0021915 | 160 | 0.015 | |
| male sex differentiation | GO:0046661 | 109 | 0.015 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.015 | |
| membrane organization | GO:0061024 | 245 | 0.015 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.015 | |
| regulation of anterior head development | GO:2000742 | 2 | 0.015 | |
| blastocyst development | GO:0001824 | 80 | 0.015 | |
| neuron fate specification | GO:0048665 | 30 | 0.015 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.015 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.015 | |
| tachykinin receptor signaling pathway | GO:0007217 | 1 | 0.015 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.015 | |
| cell division | GO:0051301 | 120 | 0.015 | |
| renal vesicle development | GO:0072087 | 17 | 0.015 | |
| sclerotome development | GO:0061056 | 4 | 0.015 | |
| appendage development | GO:0048736 | 166 | 0.015 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.015 | |
| activation of mapk activity | GO:0000187 | 59 | 0.015 | |
| motor neuron migration | GO:0097475 | 4 | 0.015 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.015 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.015 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.015 | |
